Role of FDG-PET for the treatment strategy of malignant lymphoma

S. Baba; T. Isoda; Y. Maruoka; Y. Kitamura; H. Honda; M. Sasaki

Role of FDG-PET for the treatment strategy of malignant lymphoma

S. Baba, T. Isoda, Y. Maruoka, Y. Kitamura, H. Honda, M. Sasaki

研究成果: ジャーナルへの寄稿 › 総説 › 査読

抄録

FDG-PET is increasingly being used for assessment of the staging, for evaluating the response to treatment, and for monitoring the reactions to therapy in malignant lymphoma. This review will highlight the most important applications of FDG-PET in lymphoma, focusing on the advantages and pitfalls of this imaging, and past and ongoing efforts to standardize the use of FDG-PET, particularly in response to assessment and therapy monitoring.

本文言語	英語
ページ（範囲）	1292-1301
ページ数	10
ジャーナル	Japanese Journal of Clinical Radiology
巻	59
号	10
出版ステータス	出版済み - 10月 1 2014

!!!All Science Journal Classification (ASJC) codes

放射線学、核医学およびイメージング

他のファイルとリンク

引用スタイル

@article{5b2720dfbe554d2bb591a9b1b15b9665,

title = "Role of FDG-PET for the treatment strategy of malignant lymphoma",

abstract = "FDG-PET is increasingly being used for assessment of the staging, for evaluating the response to treatment, and for monitoring the reactions to therapy in malignant lymphoma. This review will highlight the most important applications of FDG-PET in lymphoma, focusing on the advantages and pitfalls of this imaging, and past and ongoing efforts to standardize the use of FDG-PET, particularly in response to assessment and therapy monitoring.",

author = "S. Baba and T. Isoda and Y. Maruoka and Y. Kitamura and H. Honda and M. Sasaki",

year = "2014",

month = oct,

day = "1",

language = "English",

volume = "59",

pages = "1292--1301",

journal = "Japanese Journal of Clinical Radiology",

issn = "0009-9252",

publisher = "Kanehara Shuppan Co. Ltd",

number = "10",

}

TY - JOUR

T1 - Role of FDG-PET for the treatment strategy of malignant lymphoma

AU - Baba, S.

AU - Isoda, T.

AU - Maruoka, Y.

AU - Kitamura, Y.

AU - Honda, H.

AU - Sasaki, M.

PY - 2014/10/1

Y1 - 2014/10/1

N2 - FDG-PET is increasingly being used for assessment of the staging, for evaluating the response to treatment, and for monitoring the reactions to therapy in malignant lymphoma. This review will highlight the most important applications of FDG-PET in lymphoma, focusing on the advantages and pitfalls of this imaging, and past and ongoing efforts to standardize the use of FDG-PET, particularly in response to assessment and therapy monitoring.

AB - FDG-PET is increasingly being used for assessment of the staging, for evaluating the response to treatment, and for monitoring the reactions to therapy in malignant lymphoma. This review will highlight the most important applications of FDG-PET in lymphoma, focusing on the advantages and pitfalls of this imaging, and past and ongoing efforts to standardize the use of FDG-PET, particularly in response to assessment and therapy monitoring.

UR - http://www.scopus.com/inward/record.url?scp=84908701487&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908701487&partnerID=8YFLogxK

M3 - Review article

AN - SCOPUS:84908701487

SN - 0009-9252

VL - 59

SP - 1292

EP - 1301

JO - Japanese Journal of Clinical Radiology

JF - Japanese Journal of Clinical Radiology

IS - 10

ER -

Role of FDG-PET for the treatment strategy of malignant lymphoma

抄録

!!!All Science Journal Classification (ASJC) codes

他のファイルとリンク

フィンガープリント

引用スタイル